• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

中东欧部分国家口服避孕药女性使用者的需求与偏好

Needs and preferences of women users of oral contraceptives in selected countries in Central and Eastern Europe.

作者信息

Fait Tomas, Buryak Dmitry, Cirstoiu Monica-Mihaela, Luczai Eva, Janczura Rafal

机构信息

Department of Obstetrics and Gynecology, 2nd Faculty of Medicine, Charles University Prague, Motol University Hospital, Prague, Czech Republic.

Department of Obstetrics, Gynecology and Reproductive Health, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus.

出版信息

Drugs Context. 2018 Feb 7;7:212510. doi: 10.7573/dic.212510. eCollection 2018.

DOI:10.7573/dic.212510
PMID:29445408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5804877/
Abstract

BACKGROUND

The availability of various oral contraceptive (OC) pill formulations with different hormone compositions suggests that there is potential to align a particular product with an individual user's needs and preferences. To explore this concept further, a survey was conducted of current users of OCs to define and confirm areas of specific needs, and to gain insight into their views and preferences for OC formulations.

METHODS

During November and December 2015, women users (n=615) of OCs in five Central and Eastern European countries were surveyed in face-to-face interviews conducted by experienced interviewers. The survey questionnaire comprised 34 questions about the use of and specific needs for OCs.

RESULTS

Four basic needs of women taking OCs were identified: reliable contraception, reversibility of contraception, no effect on body weight and safety. Overall, 85% of surveyed women indicated that prevention of pregnancy was the main reason for taking OCs. Weight gain was the side effect of greatest concern with OC use (46% spontaneous answer; 65% aided answer). Independent behavioural segmentation analysis identified four groups - Solved Cycle Problems (46% of participants), Low Hormone Content (22%), Lifestyle (17%) and Beauty (14%) - which characterised the women according to needs and preferences beyond the basic needs of OCs. Each group had unique features and distinct preferences for different formulations of OCs.

CONCLUSIONS

Aligning product advantages with specific individual needs may enhance users' overall experience with OCs as a contraceptive option.

摘要

背景

各种具有不同激素成分的口服避孕药（OC）制剂的出现表明，使特定产品与个体用户的需求和偏好相匹配具有潜力。为了进一步探讨这一概念，对当前口服避孕药使用者进行了一项调查，以定义和确认特定需求领域，并深入了解他们对口服避孕药制剂的看法和偏好。

方法

2015年11月至12月期间，由经验丰富的访谈员对中欧和东欧五个国家的615名口服避孕药女性使用者进行了面对面访谈。调查问卷包括34个关于口服避孕药使用和特定需求的问题。

结果

确定了服用口服避孕药女性的四个基本需求：可靠避孕、避孕可逆性、对体重无影响和安全性。总体而言，85%的受访女性表示预防怀孕是服用口服避孕药的主要原因。体重增加是口服避孕药使用中最令人担忧的副作用（46%为自发回答；65%为辅助回答）。独立行为细分分析确定了四个群体——解决周期问题者（46%的参与者）、低激素含量者（22%）、生活方式者（17%）和美容者（14%）——这些群体根据口服避孕药基本需求之外的需求和偏好对女性进行了特征描述。每个群体对不同的口服避孕药制剂都有独特的特点和不同的偏好。

结论

使产品优势与特定个体需求相匹配可能会提升用户将口服避孕药作为避孕选择的总体体验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/25b5060aa1f5/dic-7-212510-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/e2a2ebd64caf/dic-7-212510-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/d076b5b253b3/dic-7-212510-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/98bafd522ea1/dic-7-212510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/5be80dd950cc/dic-7-212510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/9d67e93cfe7f/dic-7-212510-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/751863eeaf49/dic-7-212510-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/06c8a755cab5/dic-7-212510-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/25b5060aa1f5/dic-7-212510-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/e2a2ebd64caf/dic-7-212510-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/d076b5b253b3/dic-7-212510-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/98bafd522ea1/dic-7-212510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/5be80dd950cc/dic-7-212510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/9d67e93cfe7f/dic-7-212510-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/751863eeaf49/dic-7-212510-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/06c8a755cab5/dic-7-212510-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98af/5804877/25b5060aa1f5/dic-7-212510-g007.jpg

相似文献

1
Needs and preferences of women users of oral contraceptives in selected countries in Central and Eastern Europe.中东欧部分国家口服避孕药女性使用者的需求与偏好
Drugs Context. 2018 Feb 7;7:212510. doi: 10.7573/dic.212510. eCollection 2018.
2
Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation.口服避孕药的使用与滥用：服药依从性差及停药的风险指标
Contraception. 1995 May;51(5):283-8. doi: 10.1016/0010-7824(95)00074-k.
3
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".欧洲避孕协会口服避孕药调查更新：“十二国欧洲”的避孕方法
Int J Fertil Menopausal Stud. 1995;40 Suppl 2:73-9.
4
Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women.女性对避孕方法的满意度：对1466名女性使用口服避孕药、宫内节育器、避孕套、自然计划生育和绝育的身体及心理影响进行的一项人口调查。
Contraception. 1999 May;59(5):277-86. doi: 10.1016/s0010-7824(99)00034-7.
5
Population-based study of risk of venous thromboembolism associated with various oral contraceptives.基于人群的与各种口服避孕药相关的静脉血栓栓塞风险研究。
Lancet. 1997 Jan 11;349(9045):83-8. doi: 10.1016/s0140-6736(96)07496-x.
6
Effect of oral contraceptive progestins on serum copper concentration.口服避孕药孕激素对血清铜浓度的影响。
Eur J Clin Nutr. 1998 Oct;52(10):711-5. doi: 10.1038/sj.ejcn.1600631.
7
The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.口服避孕药的使用与年轻女性急性心肌梗死的发生。口服避孕药与年轻女性健康跨国研究的结果。
Contraception. 1997 Sep;56(3):129-40. doi: 10.1016/s0010-7824(97)00118-2.
8
The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.被误解的药丸：三十年的测试与研发已减少了该药丸的主要及次要副作用。
Netw Res Triangle Park N C. 1986 Summer;7(4):1-5.
9
Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994.使用口服避孕药的女性的血压：1994年英格兰健康调查结果
J Hypertens. 1997 Oct;15(10):1063-8. doi: 10.1097/00004872-199715100-00003.
10
Latest views on pill prescribing.关于药丸处方的最新观点。
J R Coll Gen Pract. 1984 Nov;34(268):611-4.

本文引用的文献

1
Oral contraception.口服避孕药。
Med Clin North Am. 2015 May;99(3):479-503. doi: 10.1016/j.mcna.2015.01.004. Epub 2015 Feb 27.
2
Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks.复方激素避孕药：处方模式、依从性以及获益与风险。
Ther Adv Drug Saf. 2014 Oct;5(5):201-13. doi: 10.1177/2042098614548857.
3
Intended and unintended pregnancies worldwide in 2012 and recent trends.2012年全球有意和意外怀孕情况及近期趋势。
Stud Fam Plann. 2014 Sep;45(3):301-14. doi: 10.1111/j.1728-4465.2014.00393.x.
4
Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations.孕二烯酮：复方避孕药制剂中其药理学、效力及耐受性的综述
Contraception. 2014 Apr;89(4):242-52. doi: 10.1016/j.contraception.2013.12.003. Epub 2013 Dec 19.
5
Shifts in intended and unintended pregnancies in the United States, 2001-2008.2001-2008 年美国计划内和计划外妊娠的变化。
Am J Public Health. 2014 Feb;104 Suppl 1(Suppl 1):S43-8. doi: 10.2105/AJPH.2013.301416. Epub 2013 Dec 19.
6
Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills.口服避孕药中所含雌激素和孕激素的特性及代谢影响。
Best Pract Res Clin Endocrinol Metab. 2013 Feb;27(1):13-24. doi: 10.1016/j.beem.2012.09.004. Epub 2012 Oct 10.
7
History of oral contraceptive drugs and their use worldwide.口服避孕药的历史及其在全球的应用。
Best Pract Res Clin Endocrinol Metab. 2013 Feb;27(1):3-12. doi: 10.1016/j.beem.2012.11.004. Epub 2012 Dec 25.
8
The influence of combined oral contraceptives on female sexual desire: a systematic review.复方口服避孕药对女性性欲的影响：一项系统综述。
Eur J Contracept Reprod Health Care. 2013 Feb;18(1):27-43. doi: 10.3109/13625187.2012.728643.
9
Effects of an oral contraceptive containing chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal contraception.含醋酸氯地孕酮和炔雌醇的口服避孕药对希望使用激素避孕的妇女毛发和皮肤质量的影响。
J Eur Acad Dermatol Venereol. 2013 May;27(5):601-8. doi: 10.1111/j.1468-3083.2012.04497.x. Epub 2012 Mar 10.
10
Oral contraceptive formulation and risk of breast cancer.口服避孕药制剂与乳腺癌风险。
Contraception. 2012 Apr;85(4):342-50. doi: 10.1016/j.contraception.2011.08.007. Epub 2011 Sep 28.